Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)
Study Details
Study Description
Brief Summary
The aim of the study is to determine the efficacy and safety of ciclesonide nasal spray in children with seasonal allergic rhinitis. Ciclesonide will be administered intranasally at two dose levels once daily. The study consists of a baseline period (1 to 3 weeks) and a treatment period (2 weeks).
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Outcome Measures
Primary Outcome Measures
- Average of morning and evening parent/caregiver reported reflective total nasal symptoms score over the two weeks of treatment []
Secondary Outcome Measures
- Physician assessment of nasal symptoms score at endpoint []
- average of morning and evening parent/caregiver reported instantaneous total nasal symptom score over the two weeks of treatment []
- safety []
Eligibility Criteria
Criteria
Main Inclusion Criteria:
-
Written informed consent
-
General good health other than seasonal allergic rhinitis
-
Positive standard skin prick test
Main Exclusion Criteria:
-
Pregnancy, nursing, or plans to become pregnant or donate gametes for in vitro fertilization
-
Participation in any investigational drug trial within the 30 days preceding the Screening Visit
-
A known hypersensitivity to any corticosteroid or any of the ingredients in the study drug formulation
-
Plans to travel outside the study area (the known pollen area for the investigative site) for 24 hours or more during the final 7 days of the baseline period
-
Plans to travel outside the study area (the known pollen area for the investigative site) for more than 2 consecutive days OR more than 3 days total during the treatment period
-
Use of any prohibited concomitant medications
-
Non-vaccinated exposure to or active infection with chickenpox or measles within the 21 days preceding the Screening Visit
-
Use of antiepileptic drugs for epilepsy within 30 days of the Screening Visit
-
Study participation by more than one patient from the same household
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Altana Pharma/Nycomed | Birmingham | Alabama | United States | 35235 |
2 | Altana Pharma/Nycomed | Hot Springs | Arkansas | United States | 71913 |
3 | Altana Pharma/Nycomed | Costa Mesa | California | United States | 92626 |
4 | Altana Pharma/Nycomed | Huntington Beach | California | United States | 92647 |
5 | Altana Pharma/Nycomed | Long Beach | California | United States | 90806 |
6 | Altana Pharma/Nycomed | Los Alamitos | California | United States | 90720 |
7 | Altana Pharma/Nycomed | Mission Viejo | California | United States | 92691 |
8 | Altana Pharma/Nycomed | Orange | California | United States | 92868 |
9 | Altana Pharma/Nycomed | Roseville | California | United States | 95678 |
10 | Altana Pharma/Nycomed | San Diego | California | United States | 92120 |
11 | Altana Pharma/Nycomed | San Diego | California | United States | 92123 |
12 | Altana Pharma/Nycomed | San Jose | California | United States | 95117 |
13 | Altana Pharma/Nycomed | Stockton | California | United States | 95207 |
14 | Altana Pharma/Nycomed | Colorado Springs | Colorado | United States | 80907 |
15 | Altana Pharma/Nycomed | Denver | Colorado | United States | 80230 |
16 | Altana Pharma/Nycomed | Englewood | Colorado | United States | 80112 |
17 | Altana Pharma/Nycomed | Lakewood, CO | Colorado | United States | 80401 |
18 | Altana Pharma/Nycomed | Atlanta | Georgia | United States | 30342 |
19 | Altana Pharma/Nycomed | Gainesville | Georgia | United States | 30501 |
20 | Altana Pharma/Nycomed | Savannah | Georgia | United States | 31406 |
21 | Altana Pharma/Nycomed | Woodstock, GA | Georgia | United States | 30188 |
22 | Altana Pharma/Nycomed | Normal | Illinois | United States | 61761 |
23 | Altana Pharma/Nycomed | Indianapolis | Indiana | United States | 46208 |
24 | Altana Pharma/Nycomed | Overland Park | Kansas | United States | 66211 |
25 | Altana Pharma/Nycomed | Louisville, KY | Kentucky | United States | 40215 |
26 | Altana Pharma/Nycomed | Metairie | Louisiana | United States | 70006 |
27 | Altana Pharma/Nycomed | Shreveport | Louisiana | United States | 71105 |
28 | Altana Pharma/Nycomed | Bethesda | Maryland | United States | 20814 |
29 | Altana Pharma/Nycomed | North Dartmouth | Massachusetts | United States | 02747 |
30 | Altana Pharma/Nycomed | Minneapolis | Minnesota | United States | 55402 |
31 | Altana Pharma/Nycomed | Jefferson City | Missouri | United States | 65109 |
32 | Altana Pharma/Nycomed | Rolla | Missouri | United States | 65401 |
33 | Altana Pharma/Nycomed | St. Louis | Missouri | United States | 63141 |
34 | Altana Pharma/Nycomed | Lincoln, NE | Nebraska | United States | 68505 |
35 | Altana Pharma/Nycomed | Papillion | Nebraska | United States | 68046 |
36 | Altana Pharma/Nycomed | Brick | New Jersey | United States | 08724 |
37 | Altana Pharma/Nycomed | Forked River | New Jersey | United States | 08731 |
38 | Altana Pharma/Nycomed | Red Bank | New Jersey | United States | 07701 |
39 | Altana Pharma/Nycomed | Skillman | New Jersey | United States | 08558 |
40 | Altana Pharma/Nycomed | Warren | New Jersey | United States | 07059 |
41 | Altana Pharma/Nycomed | Rochester, NY | New York | United States | 14618 |
42 | Altana Pharma/Nycomed | Rockville Centre | New York | United States | 11570 |
43 | Altana Pharma/Nycomed | Raleigh | North Carolina | United States | 27607 |
44 | Altana Pharma/Nycomed | Cincinnati, OH | Ohio | United States | 45231 |
45 | Altana Pharma/Nycomed | Cincinnati | Ohio | United States | 45219 |
46 | Altana Pharma/Nycomed | Ashland | Oregon | United States | 97520 |
47 | Altana Pharma/Nycomed | Lake Oswego | Oregon | United States | 97035 |
48 | Altana Pharma/Nycomed | Medford, OR | Oregon | United States | 97504 |
49 | Altana Pharma/Nycomed | Portland | Oregon | United States | 97213 |
50 | Altana Pharma/Nycomed | Blue Bell | Pennsylvania | United States | 19422 |
51 | Altana Pharma/Nycomed | Eerie | Pennsylvania | United States | 16506 |
52 | Altana Pharma/Nycomed | Pittsburgh | Pennsylvania | United States | 15202 |
53 | Altana Pharma/Nycomed | Pittsburgh | Pennsylvania | United States | 15241 |
54 | Altana Pharma/Nycomed | Upland | Pennsylvania | United States | 19013 |
55 | Altana Pharma/Nycomed | Charleston, SC | South Carolina | United States | 29407 |
56 | Altana Pharma/Nycomed | Charleston | South Carolina | United States | 29414 |
57 | Altana Pharma/Nycomed | Germantown | Tennessee | United States | 38138 |
58 | Altana Pharma/Nycomed | Jackson | Tennessee | United States | 38301 |
59 | Altana Pharma/Nycomed | Austin | Texas | United States | 78731 |
60 | Altana Pharma/Nycomed | Austin | Texas | United States | 78750 |
61 | Altana Pharma/Nycomed | Dallas | Texas | United States | 75231 |
62 | Altana Pharma/Nycomed | El Paso | Texas | United States | 79925 |
63 | Altana Pharma/Nycomed | Kerrville | Texas | United States | 78028 |
64 | Altana Pharma/Nycomed | New Braunfels | Texas | United States | 78130 |
65 | Altana Pharma/Nycomed | San Antonio | Texas | United States | 78229 |
66 | Altana Pharma/Nycomed | Salt Lake City | Utah | United States | 84037 |
67 | Altana Pharma/Nycomed | South Burlington | Vermont | United States | 05403 |
68 | Altana Pharma/Nycomed | Burke | Virginia | United States | 22015 |
69 | Altana Pharma/Nycomed | Charlottesville | Virginia | United States | 22911 |
70 | Altana Pharma/Nycomed | Richmond | Virginia | United States | 23226 |
71 | Altana Pharma/Nycomed | Milwaukee | Wisconsin | United States | 53209 |
Sponsors and Collaborators
- AstraZeneca
Investigators
- Study Director: AstraZeneca AstraZeneca, AstraZeneca
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- BY9010/M1-417